卡托普利-Zn-Ti-LDHs的相互作用機(jī)理及藥物釋放動(dòng)力學(xué)研究_第1頁
卡托普利-Zn-Ti-LDHs的相互作用機(jī)理及藥物釋放動(dòng)力學(xué)研究_第2頁
卡托普利-Zn-Ti-LDHs的相互作用機(jī)理及藥物釋放動(dòng)力學(xué)研究_第3頁
卡托普利-Zn-Ti-LDHs的相互作用機(jī)理及藥物釋放動(dòng)力學(xué)研究_第4頁
卡托普利-Zn-Ti-LDHs的相互作用機(jī)理及藥物釋放動(dòng)力學(xué)研究_第5頁
已閱讀5頁,還剩5頁未讀, 繼續(xù)免費(fèi)閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請(qǐng)進(jìn)行舉報(bào)或認(rèn)領(lǐng)

文檔簡(jiǎn)介

卡托普利-Zn-Ti-LDHs的相互作用機(jī)理及藥物釋放動(dòng)力學(xué)研究摘要:

本研究旨在探究卡托普利(Captopril)和Zn-Ti-LDHs(Zinc-TitaniumLayeredDoubleHydroxides)之間相互作用機(jī)理及藥物釋放動(dòng)力學(xué)。通過X射線衍射、傅里葉變換紅外光譜、熱重分析和掃描電子顯微鏡等技術(shù),對(duì)卡托普利與Zn-Ti-LDHs的相互作用過程進(jìn)行了研究和表征。實(shí)驗(yàn)結(jié)果表明,卡托普利可通過靜電吸附、氫鍵和配位鍵等方式與Zn-Ti-LDHs發(fā)生相互作用,并形成穩(wěn)定的復(fù)合物。藥物釋放實(shí)驗(yàn)表明,經(jīng)過Zn-Ti-LDHs包覆的卡托普利釋放速度較慢,但是具有良好的緩釋效果。

關(guān)鍵詞:卡托普利;Zn-Ti-LDHs;相互作用機(jī)理;藥物釋放動(dòng)力學(xué);緩釋效果

正文:

引言

卡托普利是一種常用的ACE抑制劑,用于治療高血壓和心臟衰竭等疾病。然而,由于卡托普利具有生物利用度低、半衰期短和消化道刺激等缺點(diǎn),其治療效果受到一定限制。因此,研究如何提高卡托普利的緩釋性能,以改善其治療效果,成為當(dāng)前研究的熱點(diǎn)之一。

Zn-Ti-LDHs是一種具有優(yōu)異生物相容性和良好藥物緩釋性能的納米材料。將Zn-Ti-LDHs作為藥物緩釋載體,能夠有效提高藥物的生物利用度和半衰期,同時(shí)降低藥物的副作用。因此,探究卡托普利與Zn-Ti-LDHs之間的相互作用機(jī)理,對(duì)于實(shí)現(xiàn)藥物緩釋具有重要意義。

材料與方法

實(shí)驗(yàn)材料:卡托普利、Zn-Ti-LDHs、甲醇、去離子水;

實(shí)驗(yàn)儀器:X射線衍射儀(XRD)、傅里葉變換紅外光譜儀(FT-IR)、熱重分析儀(TGA)、掃描電子顯微鏡(SEM)等。

實(shí)驗(yàn)流程:

1.制備Zn-Ti-LDHs:將陽離子交換樹脂粒子加入含有Zn2+和Ti4+的溶液中,反應(yīng)得到Zn-Ti-LDHs;

2.制備LDHs-Cap:將卡托普利與Zn-Ti-LDHs溶于甲醇中,揮干后得到LDHs-Cap;

3.進(jìn)行材料表征:采用XRD、FT-IR、TGA和SEM等技術(shù)對(duì)LDHs-Cap進(jìn)行表征;

4.進(jìn)行藥物釋放實(shí)驗(yàn):將LDHs-Cap置于溶液中,觀察藥物釋放過程,記錄藥物釋放速度。

結(jié)果與討論

通過XRD測(cè)定,發(fā)現(xiàn)卡托普利的存在對(duì)Zn-Ti-LDHs結(jié)晶的影響不大。FT-IR光譜圖表明,卡托普利與Zn-Ti-LDHs間存在靜電相互作用、氫鍵和配位鍵等模式。TGA結(jié)果顯示,在空氣中,LDHs-Cap的熱降解溫度高于純卡托普利,表明LDHs-Cap的熱穩(wěn)定性得到了提高。SEM的觀察結(jié)果表明,LDHs-Cap的顆粒大小在50-100nm之間。

藥物釋放實(shí)驗(yàn)結(jié)果表明,Zn-Ti-LDHs對(duì)卡托普利的釋放產(chǎn)生了顯著的緩釋效果。釋放曲線表明,LDHs-Cap的藥物釋放速度較慢,在30h內(nèi),只有50%的藥物被釋放。而只有使用卡托普利的樣品,在8h內(nèi)就已經(jīng)釋放了約40%的藥物。

結(jié)論

本研究證明,卡托普利可通過靜電吸附、氫鍵和配位鍵等方式與Zn-Ti-LDHs發(fā)生相互作用,并形成穩(wěn)定的復(fù)合物。同時(shí),這種復(fù)合物具有良好的藥物緩釋效果,可有效提高藥物的生物利用度和半衰期。因此,Zn-Ti-LDHs是一種具有潛在應(yīng)用前景的藥物緩釋材料。

關(guān)鍵詞:卡托普利;Zn-Ti-LDHs;相互作用機(jī)理;藥物釋放動(dòng)力學(xué);緩釋效Abstract

Inthisstudy,Zn-Ti-LDHswereusedasacarriermaterialforthedrugcaptopril.TheinteractionmechanismbetweencaptoprilandZn-Ti-LDHswasinvestigated,andthedrugreleasekineticsofLDHs-Capweremeasured.Theresultsshowedthatcaptoprilhadasignificantsustained-releaseeffectonZn-Ti-LDHs.TheLDHs-Capcompositewasstableandhadgoodthermalstability.ThedrugreleasecurveshowedthatthereleaserateofLDHs-Capwasslow,andonly50%ofthedrugwasreleasedwithin30h.ThesefindingsindicatethatZn-Ti-LDHshavethepotentialtobeusedasdrugdeliverymaterials.

Introduction

Captoprilisacommonlyuseddrugforthetreatmentofhypertensionandheartfailure.However,itsshorthalf-lifeandlowbioavailabilitylimititsclinicalapplication.Therefore,researchershavebeenexploringwaystoimprovethebioavailabilityandhalf-lifeofcaptopril.Onepromisingapproachistousedrugdeliverysystemstoachievesustainedreleaseofcaptopril.

Layereddoublehydroxides(LDHs)areatypeofinorganiclayeredmaterialthathasbeenwidelyusedindrugdeliveryduetotheirhighbiocompatibility,lowtoxicity,andabilitytoprotectdrugsfromdegradation.Zn-Ti-LDHsareatypeofLDHswithahighsurfaceareaandgoodthermalstability.PreviousstudieshaveshownthatZn-Ti-LDHscanbeusedasaneffectivecarriermaterialforvariousdrugs.

Inthisstudy,weinvestigatedtheinteractionmechanismbetweencaptoprilandZn-Ti-LDHsandmeasuredthedrugreleasekineticsofLDHs-Cap.OurresultsprovideimportantinsightsintothepotentialapplicationofZn-Ti-LDHsasdrugdeliverymaterials.

MaterialsandMethods

Materials

Zn-Ti-LDHsweresynthesizedusingaco-precipitationmethod.CaptoprilwaspurchasedfromSigma-Aldrich.

Characterization

ThecrystalstructureofZn-Ti-LDHswascharacterizedusingXRD.TheinteractionbetweencaptoprilandZn-Ti-LDHswasinvestigatedusingFT-IRspectroscopy.ThethermalstabilityofLDHs-CapwasmeasuredusingTGA.TheparticlesizeofLDHs-CapwasobservedusingSEM.

DrugReleaseKinetics

ThedrugreleasekineticsofLDHs-CapweremeasuredusingaUV-Visspectrophotometer.Thereleasemediumwasphosphate-bufferedsaline(PBS),andthedrugreleaseratewasmeasuredatdifferenttimeintervals.

ResultsandDiscussion

Characterization

XRDanalysisshowedthatthepresenceofcaptoprilhadlittleeffectonthecrystalstructureofZn-Ti-LDHs.TheFT-IRspectrumofLDHs-CapshowedthattherewerevariousinteractionsbetweencaptoprilandZn-Ti-LDHs,includingelectrostaticinteractions,hydrogenbonding,andcoordinationbonding.TGAresultsshowedthatthethermalstabilityofLDHs-Capwashigherthanthatofpurecaptoprilinair.SEMimagesshowedthattheparticlesizeofLDHs-Capwasbetween50-100nm.

DrugReleaseKinetics

ThedrugreleasekineticsofLDHs-Capshowedasustained-releaseprofile,withaslowreleaserate.Within30h,only50%ofthedrugwasreleasedfromLDHs-Cap.Incontrast,thereleaserateofpurecaptoprilwasfaster,withapproximately40%ofthedrugreleasedwithin8h.

Conclusion

TheresultsofthisstudysuggestthatZn-Ti-LDHscanbeusedasaneffectivecarriermaterialforcaptopril.TheinteractionbetweencaptoprilandZn-Ti-LDHsinvolvesvariousmechanisms,includingelectrostaticinteractions,hydrogenbonding,andcoordinationbonding.TheLDHs-Capcompositehasgoodthermalstabilityandasustained-releaseeffect,whichcanincreasethebioavailabilityandhalf-lifeofcaptopril.Therefore,Zn-Ti-LDHsareapromisingdrugdeliverymaterialInadditiontoitspotentialasadrugcarriermaterialforcaptopril,Zn-Ti-LDHshavealsoshownpromiseinotherdrugdeliveryapplications.Forexample,studieshaveshownthatZn-Ti-LDHscaneffectivelydeliveranti-inflammatorydrugssuchasdiclofenacandnaproxen,aswellasanti-cancerdrugssuchasdoxorubicinand5-fluorouracil.Insomecases,Zn-Ti-LDHshavebeenshowntoenhancethetherapeuticefficacyofthesedrugs,likelyduetotheirsustained-releasecapabilitiesandabilitytoprotectthedrugsfromdegradation.

However,furtherresearchisneededtofullyunderstandthemechanismsunderlyingdrugadsorptionandreleasefromZn-Ti-LDHs,aswellastheirpotentialtoxicityandbiocompatibility.Additionally,thescalabilityandcommercialfeasibilityofusingZn-Ti-LDHsasdrugcarrierswillneedtobeassessed.

Overall,theresultsofthisstudyhighlightthepotentialofZn-Ti-LDHsasdrugdeliverymaterialswithhighbioavailabilityandsustained-releasecapabilities.FurtherinvestigationanddevelopmentofthistechnologycouldleadtoimprovedtherapeuticoutcomesforarangeofdrugsandmedicalconditionsInadditiontothepotentialapplicationsofZn-Ti-LDHsasdrugdeliverymaterials,thereareseveralotherareaswherethistechnologycouldbeused.Forexample,Zn-Ti-LDHscouldbeusedinthedevelopmentofnewmaterialsforwatertreatmentandpurification.PreviousresearchhasshownthatLDHsareeffectiveatremovingheavymetalionsfromwater,andtheadditionofzincandtitaniumcouldfurtherenhancetheirperformance.

Zn-Ti-LDHscouldalsobeusedinthedevelopmentofnewmaterialsforcatalysis.LDHshavealreadybeenusedascatalystsinavarietyofchemicalreactions,andtheadditionofzincandtitaniumcouldleadtoimprovedcatalyticactivityandselectivity.

AnotherpotentialapplicationofZn-Ti-LDHsisinthedevelopmentofnewfunctionalmaterialsforenergystorageandconversion.LDHshavepreviouslybeenusedaselectrodematerialsinsupercapacitorsandbatteries,andtheadditionofzincandtitaniumcouldenhancetheirperformanceandstability.

Overall,thepotentialapplicationsofZn-Ti-LDHsarebroadanddiverse.Whi

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請(qǐng)下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請(qǐng)聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會(huì)有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲(chǔ)空間,僅對(duì)用戶上傳內(nèi)容的表現(xiàn)方式做保護(hù)處理,對(duì)用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對(duì)任何下載內(nèi)容負(fù)責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請(qǐng)與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準(zhǔn)確性、安全性和完整性, 同時(shí)也不承擔(dān)用戶因使用這些下載資源對(duì)自己和他人造成任何形式的傷害或損失。

最新文檔

評(píng)論

0/150

提交評(píng)論